文献速递瓣膜病与结构性心脏病

经股动脉TAVI中全身麻醉与非全身麻醉的比较

Comparison of general anaesthesia and non-general anaesthesia approach in transfemoral transcatheter aortic valve implantation.
PubMed 文献 · Heart · 2018-03-29

基于英国TAVI注册研究2013-2014年2243例经股动脉TAVI患者,比较全身麻醉(GA)与非全身麻醉的结局。倾向评分匹配后,GA组手术时间更长、住院时间更久,但瓣膜成功置入率、显著主动脉瓣反流发生率及30天和1年死亡率无显著差异。

要点

  • 全身麻醉与非全身麻醉在TAVI术后30天和1年死亡率无差异。
  • 全身麻醉与更长手术时间和更长住院时间相关。
  • 倾向评分匹配后上述结果保持不变。

核心结论

  • 麻醉方式不影响经股动脉TAVI的手术结局及30天和1年死亡率,但全身麻醉与更长手术时间和住院时间相关。

研究设计与样本

  • 基于英国TAVI注册数据的回顾性队列研究,纳入2013-2014年使用Edwards Sapien或Medtronic CoreValve假体的2243例患者,采用倾向评分匹配分析校正混杂因素。

主要发现

  • 2243例患者(年龄81.4±7.5岁,男性1195例)中,1816例(81%)接受全身麻醉,427例(19%)未接受全身麻醉。
  • 全身麻醉组经食管超声心动图(TOE)使用率为92.3%,非全身麻醉组为12.4%(p<0.001)。
  • 瓣膜成功置入率全身麻醉组97.2% vs 非全身麻醉组95.7%(p=0.104),术后超过轻度主动脉瓣反流发生率5.6% vs 7.0%(p=0.295)。
  • 全身麻醉组手术时间更长(131±60 vs 121±60分钟,p=0.002),住院时间更久(8.0±13.5 vs 5.7±5.5天,p<0.001)。
  • 30天和1年死亡率在两组间无差异,倾向匹配后结果不变;TOE使用与瓣膜成功置入率、显著主动脉瓣反流发生率、手术时间或住院时间无关。

临床怎么用

  • 经股动脉TAVI可考虑非全身麻醉以减少手术时间和住院时间,且不增加死亡率风险。

局限性

  • 回顾性注册研究设计,可能存在未测量的混杂因素;仅纳入2013-2014年使用特定假体的患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Performing transfemoral transcatheter aortic valve implantation (TAVI) without general anaesthesia (GA) has been increasingly adopted. We sought to study the impact of GA and non-GA approaches on procedural outcome and 30-day and 1-year mortality in transfemoral TAVI. METHODS: The UK TAVI registry holds information for every TAVI procedure in the UK. We analysed the data for patients implanted during 2013-2014 using either an Edwards Sapien or a Medtronic CoreValve prosthesis. Propensity score-matching analysis was performed to adjust for confounding factors. RESULTS: 2243 patients were studied (aged 81.4±7.5 years, 1195 males). 1816 (81%) underwent TAVI with GA and 427 (19%) without GA. Transoesophageal echocardiography (TOE) was used in 92.3% of GA and 12.4% of non-GA cases (p<0.001). There was no significant difference in the rate of successful valve deployment (GA 97.2% vs non-GA 95.7%, p=0.104) and in the incidence of more than mild aortic regurgitation (AR) at the end of the procedure (GA 5.6% vs non-GA 7.0%, p=0.295). However, procedure time was longer (131±60 vs 121±60mins, p=0.002) and length of stay was greater (8.0±13.5 vs 5.7±5.5 days, p<0.001) for GA cases. 30-day and 1-year mortality rates did not differ between the GA and non-GA cases. After propensity matching, these results remained unchanged. A second propensity analysis (adjusted for mode of anaesthesia) did not show an association between use of TOE and rate of successful valve deployment or frequency of significant AR. Neither was TOE associated with a longer procedural time or greater length of stay. CONCLUSION: Procedure outcome, and 30-day and 1-year mortality are not influenced by mode of anaesthesia. However, GA is associated with longer procedure duration and greater length of stay.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Eskandari M, Aldalati O, Dworakowski R, et al. Comparison of general anaesthesia and non-general anaesthesia approach in transfemoral transcatheter aortic valve implantation. Heart. 2018. PMID: 29599379. doi:10.1136/heartjnl-2017-312559

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。